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We also agree with Ridola and Riggio that the presence of minimal HE is predictive of incident overt HE. (2) However, minimal HE is not routinely evaluated in clinical practice. Further, studies of minimal HE diagnostics, such as the animal naming test, (3) uniformly excluded patients with psychiatric disorders, alcohol misuse in the previous 6 months, any psychoactive medication, and heart, respiratory, or renal failure. These comorbidities characterize roughly half of our cohort. The optimal cutoffs as well as their performance in real-world patients require future study. To effectively risk-stratify real-world patients in an intention-to-screen fashion, future studies of multimodal approaches, including our risk score and other modalities such as the EncephalApp and the animal naming test, are indicated.
Ridola and Riggio raised three additional issues that deserve clarification. First, validation: we performed an internal validation using a bootstrapping method. Second, we excluded patients with a history of overt HE at baseline. Our goal was to predict incident overt HE and not recurrent HE as patients with a history of overt HE are known to be at high risk of recurrent HE. Third, albumin levels can vary and are subject to confounding by malnutrition and ascites. We agree. However, both malnutrition (associated with sarcopenia or zinc deficiency) and ascites (an indicator of severe portal hypertension) are also expected to be associated with the risk of HE.
Intention-to-Treat Survival Benefit in Liver Transplantation: Comments on Lai et al.
TO THE EDITOR:
We read with interest the article of Lai et al. (1) which introduced an intention-to-treat (ITT) survival benefit of liver transplantation (LT) in patients with hepatocellular cancer (HCC).
The researchers developed two models: a pre-LT model (non-LT survival model) and a post-LT model (ITT LT survival model). This split into two models is not innovative as is stated, ignoring Merion et al. (2) and Schaubel et al. (3) The researchers underlined the importance of the informative censorship in the pre-LT model. However, they did not retain methods such as the inverse probability of censoring weighting method, (4) which overcomes dependent censoring, even in waiting list (WL) patients. (3) They split their WL candidates into two subgroups according to LT. In the LT subgroup, they estimated the survival using the MESIAH (Model to Estimate the Survival In Ambulatory patients with HCC) score. (5) This score was developed on HCC patients followed from the time of HCC assessment, which is different from the wait-listing time. Therefore, this score appears inappropriate to estimate survival in the WL condition. Even if it had been, a past external validation of the MESIAH score would have been expected.
The researchers estimated the survival benefit as the difference between ITT LT median and the non-LT median survival estimations for each patient. Did the researchers estimate a survival curve and then the survival median for each patient, defined by his or her covariates vector, giving patients with the same vector of covariates the same median? Given that the estimations were truncated at month 120, was the median observable in each subgroup of patients? Of note, in France, the median survival is not observed at 10 years (regardless of the diagnosis). The researchers did not comment on Schaubel et al., (3) which used the "true" value of life expectancy (area under the curve). Would this latter method lead to the same results?
Can the researchers comment on why they chose the same set of covariates in the survival models for LT and non-LT patients? It is unclear whether the researchers used candidates on the WL in the multivariate least square regression (MLSR); was it the case?
The selection process of only four prediction covariates among nine retained in the MLSR is not clearly explained. It would have been useful to have a summary of the model with only the selected covariates in order to justify the chosen subgroups. 
